A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five
Home ยป
Study explores impact of surgical delay for renal cell carcinoma during COVID-19 pandemic
During the peak of the COVID-19 pandemic, several elective surgeries for renal cell carcinoma, the most common type of kidney